CONTACTS 

SUBJECTS
Meeting the doctor Agenda Progress Beginning 7th Treatment Cycle   05

0403 -
0403 -    ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS 44 0000. ref SDS 41 0000.
040502 -
040503 - Patient cleared for the next cycle of Avastin and Taxol.  CA 15-3
040504 - cancer marker test results show another rise from 44 to 49.  The
040505 - doctor described CA 15-3 test results as "flat" over the past few
040506 - months that has remained above the normal target range, and so
040507 - presents a dilemma to be resolved with additional input. ref SDS 0
040508 - GJ5M  Side effects continue to worsen without explanation from
040509 - testing; the doctor suggested return to work should be 3.5 days per
040510 - week while monitoring effects to avoid overextending lowered
040511 - resistance to side effects. ref SDS 0 RZ4I  Other symptoms continue to
040512 - decline; patient reports lump under the arm is smaller, ref SDS 0
040513 - MW8J, lumps in the neck are essentially imperceptible, ref SDS 0 8R6M;
040514 - and, the redness of inflammed left breast is nearly gone, and the
040515 - wound from the punch biopsy is almost fully healed. ref SDS 0 6T5G
040516 - The doctor made arrangement for Kaiser to submit medical records to
040517 - Stanford and to UCSF for further input on resolving treament dilemmas.
040518 - ref SDS 0 AW6M
040519 -
040520 -
040521 -
040522 -
040523 -
040524 -
040525 -
040526 -
040528 -  ..
0406 -
0407 -
0408 - Discussion
0409 -
040901 - Agenda Progress Review Begin 7th Cycle Avastin Trial & Taxol
040902 -
040903 - Follow up ref SDS 44 SM6M, ref SDS 41 RO5I.
040904 -
040905 - The meeting today was regularly scheduled for starting the 7th cycle
040906 - of the protocol on the Avastin drug trial.  The meeting was held two
040907 - (2) days prior to getting treatment today in order to accomodate
040908 - the doctor's schedule, ref SDS 43 0001, and follows up the meeting
040909 - on 040909 starting the 6th cycle of the trial. ref SDS 44 SM6M
040911 -  ..
040912 - Millie created an agenda on the marking board...
040913 -
040914 -        CA 15-3 Diagnostic Test.................... ref SDS 0 GJ5M
040915 -        CT Test report............................. ref SDS 0 NL4N
040916 -        Coughing, heavy chest, breathing
040917 -        issues continue............................ ref SDS 0 RZ4I
040918 -        Lumps under arm............................ ref SDS 0 MW8J
040919 -        Lumps in neck smaller...................... ref SDS 0 8R6M
040920 -        Breast redness mastectomy
040921 -        surgery schedule........................... ref SDS 0 6T5G
040922 -        Transfer medical records
040923 -        for 2nd opinion............................ ref SDS 0 AW6M
040924 -
040925 -
040926 -
040927 -
0410 -

SUBJECTS
CA 15-3 Cancer Marker 49 Rises from 44 Continuing Rise Conflicting w

1203 -
120401 -  ..
120402 - Recovery Progress CA 15-3 Cancer Marker Rises from 44 to 49
120403 - CA 15-3 Cancer Marker Continues Strong Rise Conflicting with Pathology
120404 -
120405 - Follow up ref SDS 44 087J, ref SDS 41 087J.
120407 -  ..
120408 - The doctor submitted results of the CA 15-3 test on blood drawn
120409 - for chemotherapy on 040923, because at that time the results were not
120410 - available. ref SDS 45 2N5J  The test on 040923 shows CA 15-3 had risen
120411 - from 44 to 49....
120412 -
120413 -              [On 041007 blood test shows CA 15-3 suddenly dropped
120414 -              dramatically to 39, which is the high end of normal,
120415 -              ref SDS 49 2N5J; and is cited again the following week on
120416 -              041014. ref SDS 52 2N5J
120418 -           ..
120419 -          040923......... 49 H............. 041005, ref SDS 0 087J
120420 -          040908......... 44 H............. 040909, ref SDS 44 087J
120421 -          040825......... 47 H............. 040812, ref SDS 44 087J
120422 -          040811......... 42 H............. 040812, ref SDS 41 087J
120423 -          040728......... 43 H............. 040729, ref SDS 39 2N5J
120424 -          040712......... 54 H............. 040713, ref SDS 38 2N5J
120425 -          040628......... 47 H............. 040713, ref SDS 37 087J
120426 -          040614......... 55 H............. 040615, ref SDS 36 PX6X
120427 -          040517......... 78 H............. 040601, ref SDS 32 2N5J
120428 -          040311......... 70 H............. 040318, ref SDS 24 SM6M
120429 -          040205......... 60 H............. 040211, ref SDS 22 SM6M
120430 -          031201......... 62 H............. 031205, ref SDS 21 SM6M
120431 -          030912......... 66 H............. 030915, ref SDS 20 SM6M
120432 -          030708......... 68 H............. 030710, ref SDS 19 SM6M
120433 -          030503......... 54 H............. 030508, ref SDS 18 SM6M
120434 -          030403......... 45 H............. 030508, ref SDS 18 SM6M
120435 -          030215......... 46 H............. 030220, ref SDS 17 5E6L
120436 -          030106......... 37 H............. 030109, ref SDS 16 SM6M
120437 -          021202......... 41 H?............ 021204, ref SDS 14 SP5G
120438 -          021111......... 36 H?............ 021113, ref SDS 13 Y65I
120439 -          021023......... 33 H?............ 021023, ref SDS 12 SQ5I
120440 -          020930......... 33 H?..29........ 021002, ref SDS 11 SQ5I
120441 -          020917......... 36 H?............ 020924, ref SDS 10 SQ5I
120442 -          020717......... 59 H?............ 020726, ref SDS 9 YN5K
120443 -          020629......... 75 H ............ 020705, ref SDS 8 UX6I
120444 -          020608........  67 H ............ 020614, ref SDS 7 0001
120445 -          020603........ 108 H ............ 020607, ref SDS 6 X67F
120446 -          020511........ 117 H ............ 020603, ref SDS 5 PJ4J
120447 -          020419......... 81 H ............ 020430, ref SDS 4 7N5H
120448 -          020321......... 85 H ............ 020405, ref SDS 3 6T8K
120449 -
120450 -
120451 -
120453 -  ..
1205 -
1206 -
1207 - Analysis
1208 -
120801 - CA 15-3 49 Cancer Marker Continues Rise Presenting Treatment Dilemma
120802 -
120803 - Follow up ref SDS 44 GJ5M, ref SDS 41 GJ5M.
120804 -
120805 - The doctor drew a graph on the marking board to demonstrate his
120806 - description of CA 15-3 showing a relatively "flat" condition, yet
120807 - steadily rising above the target range of 39 since reaching a low
120808 - point of 42 reported two (2) months ago during the meeting on 040812.
120809 - ref SDS 41 GJ5M  He feels continued rise now up to 49 reported today,
120810 - per above, ref SDS 0 087J, conflicts with the favorable report on the
120811 - CT test on 040921 which presents an impression of "no adenopathy,"
120812 - ref SDS 0 WV5W, and so illustrates a difficult dilemma, as presented
120813 - to the patient during the meeting on 040812. ref SDS 41 4I6I
120815 -  ..
120816 - Previously, when CA 15-3 was on a steadily rising path, and imaging
120817 - tests with PET scans reported cancerous masses, the doctor changed
120818 - chemotherapy treatment from Adriamycin Cytoxin to Taxotere, reported
120819 - on 020603. ref SDS 5 WO4O  The doctor feels the favorable CT test
120820 - report therefore presents a dilemma.
120821 -
120822 -     [On 041007 CA 15-3 drops dramatically to 39 which is normal;
120823 -     aligns with favorable CT test report of no adenopathy. ref SDS 49
120824 -     J55J
120826 -      ..
120827 -     [On 041104 dilemma resolved when CT test shows pulmonary emoboli
120828 -     (blood clots) attributed to Avastin chemotherapy treatment
120829 -     reported to cause death in some patients, and may have caused
120830 -     coughing, heavy chest, and shortness of breath, forced patient to
120831 -     end treatment with Avastin; presents new dilemma because leaving
120832 -     the Taxol and Avastin trial conflicts with requirement for
120833 -     continuous treatment to avoid symptoms of IBC to increase, and
120834 -     which had decreased under Taxol and Avastin. ref SDS 54 N43I
120836 -  ..
120837 - Resolution of diagnostic dilemma led to plans for 2nd opinions to
120838 - obtain additional analysis from IBC experts, discussed on 040909,
120839 - ref SDS 44 AW6M, and again today, per below. ref SDS 0 AW6M
120840 -
120841 -     [On 041104 positive response to treatment shown by dramatic drop
120842 -     in CA 15-3 to normal was not discussed, ref SDS 54 GJ5M, due to
120843 -     concern about Avastin treatments causing pulmonary emboli (blood
120844 -     clots), resulting in ending treatments. ref SDS 54 GJ5M
120845 -
120846 -
120847 -
120848 -
120849 -
120850 -
120851 -
1209 -

SUBJECTS
Medical Tests Conflicts CT Not Resolved with Precision
CT Test 040921 Shows Significant Progress Toward Recovery Metastatic
IBC Surgery Masectomy Not Required Dilemma Surgery or Avastin Trial

2105 -
210601 -  ..
210602 - CT Test 040921 Shows Significant Progress Toward Recovery
210603 - Metastatic Cancer No Evidence in CT Test Report on 040921
210604 -
210605 - Follow up ref SDS 41 T761, ref SDS 40 H85S.
210606 -
210607 - The doctor submitted the CT test dated 040921, and noted the analyst's
210608 - impression of "No adenopathy."  He said this means that testing with
210609 - CT methods finds no evidence of cancer, and that the patient has
210610 - responded favorably to treatment.  The doctor advised caution because
210611 - CA 15-3 rose slightly again, per above. ref SDS 0 087J
210612 -
210613 -        [On 041007 CA 15-3 drops dramatically to 39 which is normal;
210614 -        aligns with favorable CT test report of no adenopathy.
210615 -        ref SDS 49 J55J
210617 -         ..
210618 -        [On 041104 CT test on 041103 shows pulmonary emboli; Millie
210619 -        removed from treatment on Avastin/Taxol drug trial. ref SDS 54
210620 -        RZ4I
210622 -  ..
210623 - This complements the record of prior tests listed on 040416 reporting
210624 - on the CT test that set a baseline for the Avastin trial.
210625 -
210626 -              Prior Tests
210627 -
210628 -              040710 reported on 040811.............. ref SDS 40 DU9I
210629 -              040410 reported on 040416.............. ref SDS 27 HX4K
210630 -              040307 reported on 040318.............. ref SDS 18 LK5L
210631 -              031031 reported on 031205.............. ref SDS 18 IG9K
210632 -              030626 reported on 030710.............. ref SDS 18 AL6N
210633 -              030428 reported on 030508.............. ref SDS 18 LK5L
210635 -  ..
210636 - CT test dated 040921 shows....
210638 -     ..
210639 -    Patient
210642 -     ..
210643 -    Personal Physician:
210646 -     ..
210647 -    68/F Radiology Report               Exam  1 of 1
210648 -    Page 1
210650 -     ..
210651 -    CT of the neck, chest, abdomen and pelvis (digital)
210653 -     ..
210657 -     ..
210658 -    History
210660 -     ..
210661 -    Breast Ca on taxol
210663 -     ..
210664 -    Findings
210666 -     ..
210667 -    Compare 040710:  There is no cervical mass or significant
210668 -    adenopathy, there is no node larger than 7 mm.
210670 -     ..
210671 -    There is stable post-operative change in the left axilla but no
210672 -    adenopathy.  The lungs are unchanged, free of new nodules,
210673 -    infiltrates or masses.  There are no pleural effusions.  There are
210674 -    no hilar or mediastinal masses seen.  The heart is normal in size.
210676 -     ..
210677 -    The liver cyst is unchanged.  The spleen, pancreas and adrenal
210678 -    glands are normal.  The kidneys are unremarkable.  The aorta is
210679 -    normal in caliber.  There is no adenopathy and no evidence of free
210680 -    fluid.  Scans through the pelvis are unremakrable.  There are
210681 -    degenerative skeletal changes.
210683 -     ..
210684 -    Impression
210686 -     ..
210687 -    No adenopathy.
210688 -
210689 -        [On 041007 CA 15-3 drops dramatically to 39 which is normal;
210690 -        aligns with favorable CT test report of no adenopathy.
210691 -        ref SDS 49 J55J
210693 -     ..
210694 -    A. Fisch, MD
210696 -     ..
210697 -    DD:  040924   DT:  040924   AYF
210698 -
210699 -
210700 -
210701 -
210702 -
2108 -

SUBJECTS
Breathing Problem Continuous Coughing for Several Hours Heavy Chest

3003 -
300401 -  ..
300402 - Dilemma Symptoms Life Threatening Malady Testing Finds No Evidence
300403 - Work Return Plans Questionable Kaiser Proposes 3.5 Day Work Week
300404 - Coughing Bleeding Nose Heavy Chest Breathing Low Energy Worsening
300405 -
300406 - Follow up ref SDS 44 RZ4I, ref SDS 41 RZ4I.
300407 -
300408 - Millie reported worsening cough, nose bleeding, heavy chest,
300409 - difficulty breathing, and fatigue, especially going up stairs, but
300410 - even with normal activity like walking a few blocks.  Millie had to
300411 - stop going to exercise class entirely.  Plans for returning to work
300412 - are impacted by these worsening conditions.  The doctor proposed
300413 - starting with 3.5 days per week, with half-days for blood tests the
300414 - day before getting chemotherapy treatments.
300415 -
300416 -    [On 041210 nose bleed side effects subside after ending
300417 -    treatment with bevacizumab. ref SDS 56 FL8G
300419 -  ..
300420 - The doctor feels the report for the recent CT test on 040921, and
300421 - received from Kaiser today, per above, ref SDS 0 NL4O, confirms prior
300422 - CT testing showing no cardiopulmonary problems, as reviewed last month
300423 - on 040909. ref SDS 44 RZ4I  The doctor emphasized again today that for
300424 - 6 months three (3) CT tests have shown no evidence of Millie having
300425 - any cardopulmonary disorders, which have caused death of patients
300426 - getting treatment with Avastin (bevacizumab) on the clinical study, as
300427 - discussed previously on 040812. ref SDS 41 MG4G
300429 -  ..
300430 - The doctor feels that Kaiser's CT testing supports continued treatment
300431 - on the Taxol bevacizumab (Avastin) drug trial.  He noted that Millie's
300432 - cancer marker has dropped, per above. ref SDS 0 GJ5M  Examinations
300433 - show Millie's IBC rash is subsiding, ref SDS 0 6T5G, and the CT test
300434 - today shows no evidence of distant metastasis. ref SDS 0 WV5W
300435 -
300436 -    [On 041007 CA 15-3 drops dramatically to 39 which is normal; aligns
300437 -    with favorable CT test report of no adenopathy. ref SDS 49 J55J
300439 -  ..
300440 - The doctor explained that Kaiser has no explanation for worsening
300441 - cough, shortness of breath, bleeding nose, and fatigue, but Millie
300442 - should not worry, because CT tests show no life threatening risks of
300443 - pulmonary embolism.  The doctor explained that rising cough, fatigue,
300444 - shortness of breath, and heavy chest are side effects from loss of
300445 - fitness that commonly occur with chemotherapy, and so must be endured
300446 - in order to benefit from treating cancer on the Taxol bevacizumab
300447 - (Avastin) drug trial.
300448 -
300449 -    [On 061020 1640 Kaiser discloses that tests to check for pulmonary
300450 -    embolism require a special form of CT test using thin slice
300451 -    technology, ref SDS 60 S56G; not ordering thin slice CT tests
300452 -    explains why multiple tests in 2004 delayed diagnosis of pulmonary
300453 -    embolism for 6 months. ref SDS 0 OG3I
300455 -     ..
300456 -    [On 090406 1512 shortness of breath while hiking, and later
300457 -    prevented sleep during the night; but one time event, and so not
300458 -    investigated for PE nor pneumonia. ref SDS 62 RE3T
300460 -  ..
300461 - Millie advised the doctor of work under way to get 2nd opinions from
300462 - UCSF and Stanford Cancer Centers to help Kaiser resolve dilemma of
300463 - worsening symptoms without diagnosis nor treatment, per below.
300464 - ref SDS 0 AW6M
300466 -  ..
300467 - Case study on medical mistakes is listed on 040416. ref SDS 27 GN7J
300468 -
300469 -    [On 041018 symptoms presented to Doctor Benz at UCSF for 2nd
300470 -    opinion. ref SDS 53 LX96
300472 -     ..
300473 -    [On 041104 day before on 041103 doctor ordered emergency CT test
300474 -    same day at 2000 hours at night. ref SDS 54 NL4N
300476 -     ..
300477 -    [On 041104 dilemma resolved when CT test shows pulmonary emoboli
300478 -    (blood clots) attributed to Avastin chemotherapy treatment reported
300479 -    to cause death in some patients, and may have caused coughing,
300480 -    heavy chest, and shortness of breath, forced patient to end
300481 -    treatment with Avastin; presents new dilemma because leaving the
300482 -    Taxol and Avastin trial conflicts with requirement for continuous
300483 -    treatment to avoid symptoms of IBC to increase, and which had
300484 -    decreased under Taxol and Avastin. ref SDS 54 N43I
300486 -     ..
300487 -    [On 041104 Kaiser prescribed warfarin (Coumadin) to treat Millie
300488 -    for the rest of her life to prevent pulmonary embolism.
300489 -    ref SDS 54 4Y9G
300491 -     ..
300492 -    [On 041117 Doctor Benz reported in a 2nd opinion that Kaiser is
300493 -    "investigating" patients chronic symptoms of cough, shortness of
300494 -    breath, heavy chest, and fatigue; Kaiser may have advanced the CT
300495 -    test to "investigate" for pulmonary emboli, at the suggestion of
300496 -    Doctor Benz, which is otherwise not explained. ref SDS 55 OT5Q
300498 -     ..
300499 -    [On 041230 CT test on 041217 says pulmonary embolism is no
300500 -    longer visualized. ref SDS 57 PW3K
300502 -     ..
300503 -    [On 060722 oldest son reports doctors performed tests and found
300504 -    genetic cause of blood clots that will require continuing
300505 -    treatment. ref SDS 58 3D9T
300507 -     ..
300508 -    [On 060722 case study shows patient history of 6 month delay
300509 -    discovering pulmonary embolism using CT testing, and no explanation
300510 -    of risng symptoms. ref SDS 58 6G6O
300512 -     ..
300513 -    [On 061002 Millie diagnosed with recurrence pulmonary emboli;
300514 -    requires treatment again with Lovenox to relieve blood clots, then
300515 -    continuing treatment with Coumadin to prevent recurrence.
300516 -    ref SDS 59 JK7J
300518 -     ..
300519 -    [On 070510 UCSF maintains that until cardiopulmonary disorders rise
300520 -    to visibility using CT tests without thin slice spiral CT
300521 -    technology, doctors and patients have nothing to worry about.
300522 -    ref SDS 61 KD84
300523 -
300524 -
300525 -
300526 -
3006 -

SUBJECTS
Meeting with Doctor about Lump in left breast and Under Left Arm Cau
Swelling Left Side Under Left Arm Likely Caused by Draining Lymph No
Symptom New Lump Under Arms where Cancer Surgery Performed on 020312
Pea-like Cluster and Firmness Indicates Cancerous Lumps Not Present
Lumps Under Left Arm Smaller Demonstrate Favorable Response to Treat

3707 -
370801 -  ..
370802 - Lumps Under Arm Seem Less Severe Today
370803 -
370804 - Follow up ref SDS 44 MW8J, ref SDS 41 MW8J.
370805 -
370806 - Millie reported the lump seems to still be getting smaller, continuing
370807 - prior report of response to treatment, reported last month on 040909.
370808 - ref SDS 44 MW8J
370809 -
370810 -
370811 -
370812 -
370813 -
3709 -

SUBJECTS
Lumps Neck Nearly Gone No Clinical Examination

4303 -
430401 -  ..
430402 - Lumps in Neck Seem Less Severe Nearly Gone Today
430403 -
430404 - Follow up ref SDS 44 8R6M, ref SDS 41 8R6M.
430405 -
430406 - There was no examination of lumps in the neck.  Examination the past
430407 - few months has shown the lumps are now nearly imperceptible to human
430408 - touch, showing continued improvement from CT test taken on 040710, and
430409 - reviewed on 040812, ref SDS 41 8R6M, citing the test report in the
430410 - record on 040811. ref SDS 40 WV66
430411 -
430412 -
430413 -
430414 -
430415 -
430416 -
430417 -
4305 -

SUBJECTS
Redness Inflammation Left Breast IBC Greatly Reduced No Clinical Exa

5103 -
510401 -  ..
510402 - Inflammatory Breast Cancer (IBC) Symptoms Greatly Improved
510403 - Redness Breast Seems Less Severe; Skin Seems Softer after Treatments
510404 -
510405 - Follow up ref SDS 44 6T5G, ref SDS 41 6T5G.
510406 -
510407 - There was no examination of the left breast today.  Millie reported
510408 - continued improvement with reduction of inflamation where redness has
510409 - largly receded, and the sore from the punch biopsy taken on 040419 has
510410 - nearly healed, so that it no longer seeps, indicating favorable
510411 - response to treatment on the Taxol bevacizumab drug trial, cited by
510412 - the doctor during the meeting on 040909. ref SDS 44 6E62
510413 -
510414 -
510415 -
5105 -

SUBJECTS
Medical Tests Conflicts CT Not Resolved with Precision
2nd Opinion Patient Demand Kaiser Make Referral for Input from Cance
CT Test 040710 Shows Significant Progress Toward Recovery No Evidenc
2nd Opinion Metastatic Cancer Treatment Chemotherapy New Trial Drug
600 Dollars Patients Must Pay for 2nd Opinion Metastatic Cancer Trea
2nd Opinion Verify Scope of Problem and Treatment Planning Tumor Boa
Tumor Board Report Requires Support Showing What was Reviewed Poor Q
IBC Surgery Masectomy Not Required Dilemma Surgery or Avastin Trial
2nd Opinion IBC Verify Scope of Problem Doctor Recommends Defer Gett
2nd Opinion Doctor Makes Arrangements to Transfer Medical Records fo
Stanford Medical Center Cancer Center 2nd Opinion Doctor Guardino
Medical Records Transfer for Referral to Stanford Medical Center and

7214 -
721501 -  ..
721502 - 2nd Opinion Verify Scope of Problem and Treatment Planning
721503 -
721504 - Follow up ref SDS 44 AW6M, ref SDS 41 T75L.
721505 -
721506 - Millie reviewed planning for a second opinion developed on 041002,
721507 - ref SDS 46 0001, and yesterday on 041004, ref SDS 47 0001, based on
721508 - notice to Kaiser on 040909 during the meeting with the doctor, who
721509 - noted at that time need for 2nd opinion, ref SDS 44 AW6M, and research
721510 - showing requirements for a referral reviewed on 041002, ref SDS 46
721511 - FA8O, to resolve dilimma cited again this morning by the doctor, per
721512 - above, ref SDS 0 GJ5M, and discussing worsening side effects that
721513 - Kaiser cannot treat. ref SDS 0 RZ4I
721515 -  ..
721516 - Millie explained plans to get a 2nd opinion from the Cancer Center at
721517 - Stanford Medical Center on 041019, and also to get a 2nd opinion from
721518 - the Cancer Center at UCSF, as shown in the record on 041002,
721519 - ref SDS 46 K138, per recommendations by the doctor shown in the record
721520 - on 040909. ref SDS 44 X836
721522 -  ..
721523 - The doctor noted benefits of 2nd opinions for due diligence in complex
721524 - cases, cited in Kaiser's Healthwise Handbook. ref SDS 1 455N  An
721525 - example was the 2nd opinion 4 months ago from the Surgery Department
721526 - with a pathology report that diagnosed Millie has IBC, which changed
721527 - her status from stage IIa to stage IV cancer, reported on 040614.
721528 - ref SDS 35 6M9H  This alerted the team that more work was needed to
721529 - overcome the prognosis that Millie has only months to live, also,
721530 - reported on 040614. ref SDS 35 QH8F
721532 -  ..
721533 - The doctor further offered to coordinate transfer of medical records
721534 - in order to reduce the cost, and ensure timely, complete review for
721535 - 2nd opinion consultation.
721537 -  ..
721538 - He left the examination room for about 15 minutes.
721540 -  ..
721541 - When he returned, the doctor said that he made arrangements with his
721542 - nurse for Kaiser to submit medical records for a 2nd opinion.
721543 -
721545 -  ..
7216 -
7217 -
7218 - 0942
7219 -
721901 - After meeting with the doctor, Millie talked to the nurse at the
721902 - administration area.  She said that all arrangements have been made
721903 - for Kaiser to assemble and transfer medical for case review and 2nd
721904 - opinions.  She said the patient will have to visit the Business Office
721905 - to sign a form authorizing Kaiser to send out medical records.
721906 -
721907 -     [On 041007 Tangi in the Kaiser Business Office could not find
721908 -     paperwork on transferring medical records for a 2nd opinion, and
721909 -     so initiative the transaction. ref SDS 50 GI9F
721911 -      ..
721912 -     [On 041014 received patient medical history from Kaiser, organized
721913 -     documents, corrected errors and omissions, separated tests, and
721914 -     prepared summary index of chronology to facilitate review for 2nd
721915 -     opinions. ref SDS 51 0001
721916 -
721917 -
721918 -
721919 -
721920 -
721921 -
721922 -
721923 -
721924 -
7220 -